58-17b-627. Prescription of drugs or devices by a pharmacist.
439 words·~2 min read·
/ut/title-58/chapter-17b/58-17b-627A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Effective 5/6/2026
58-17b-627. Prescription of drugs or devices by a pharmacist.
(1)Beginning January 1, 2022, a pharmacist may prescribe a prescription drug or device if:
(a)prescribing the prescription drug or device is within the scope of the pharmacist's training and experience;
(b)the prescription drug or device is designated by the division by rule under Subsection (3)(a) ; and
(c)the prescription drug or device is not a controlled substance that is included in Schedules I, II, III, or IV of:
(i)Section 58-37-108 ; or
(ii)the federal Controlled Substances Act, Title II, P.L. 91-513.
(2)Nothing in this section requires a pharmacist to issue a prescription for a prescription drug or device.
(3)The division shall make rules in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act , to:
(a)designate the prescription drugs or devices that may be prescribed by a pharmacist under this section, beginning with prescription drugs or devices that address a public health concern that is designated by the Department of Health and Human Services, including:
(i)post-exposure HIV prophylaxis;
(ii)pre-exposure HIV prophylaxis;
(iii)self-administered hormonal contraceptives;
(iv)smoking cessation;
(v)naloxone;
(vi)fluoride;
(vii)vaccines; and
(viii)epinephrine.
(b)create guidelines that a pharmacist must follow when prescribing a prescription drug or device, including guidelines:
(i)for notifying the patient's primary care or other health care provider about the prescription; and
(ii)to prevent the over-prescription of drugs or devices including but not limited to antibiotics;
(c)address when a pharmacist should refer the patient to an appropriate health care provider or otherwise encourage the patient to seek further medical care; and
(d)implement the provisions of this section.
(4)The division shall make rules under Subsection
(3)in collaboration with:
(a)individuals representing pharmacies and pharmacists;
(b)individuals representing physicians and advanced practice clinicians; and
(i)if the executive director of the Department of Health and Human Services is a physician, the executive director of the Department of Health and Human Services;
(ii)if the executive director of the Department of Health and Human Services is not a physician, a deputy director who is a physician in accordance with Subsection 26B-1-203(4) ; or
(iii)a designee of the individual described in Section 26B-1-203 .
(5)Before November 1 of each year, the division, in consultation with the individuals described in Subsection
(4), shall:
(a)develop recommendations for statutory changes to improve patient access to prescribed drugs in the state; and
(b)report the recommendations developed under Subsection (5)(a) to the Health and Human Services Interim Committee.
Amended by Chapter 362 , 2026 General Session